![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Bone Mineral Density in Children With HIV-1 Receiving TAF-Based Antiretroviral Therapy
|
|
|
CROI 2024 March 3-6 Denver
Natella Rakhmanina1, Aditya Gaur2, Jaime Gerardo Deville3, Pope Kosalaraksa4, Renate Strehlau5, Eva Natukunda6, Elizabeth Castaño7, Vinicius Adriano Vieira8, Kathryn Kersey8, Rory Leisegang8, Susanne Crowe8, Catherine M Gordon9,*
1The George Washington University, Washington, DC, USA; 2St Jude Children's Research Hospital, Memphis, TN, USA; 3Mattel Children's Hospital, University of California, Los Angeles, CA, USA; 4Khon Kaen University, Khon Kaen, Thailand; 5University of the Witwatersrand, Johannesburg, South Africa;
6Joint Clinical Research Centre, Kampala, Uganda; 7Hospital del Niño, Panama City, Panama; 8Gilead Sciences, Inc., Foster City, CA, USA; 9Baylor College of Medicine, Houston, TX, USA
*At the time of the study, now Division of Intramural Research, Eunice Kennedy Shriver NICHD, Bethesda, MD, USA
![0311241](../images/031124/031024-3/0311241.gif)
![0311242](../images/031124/031024-3/0311242.gif)
![0311243](../images/031124/031024-3/0311243.gif)
![0311244](../images/031124/031024-3/0311244.gif)
![0311245](../images/031124/031024-3/0311245.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|